ODDB.org: Open Drug Database

Novartis Pharma Schweiz AG - Jadenu 180 mg, Filmtabletten

Swissmedic Registration	65867	Sequence	02
Product name	Jadenu 180 mg	Description	Filmtabletten
ATC-Classification	V03AC03	ATC-Description	Deferasirox
Introduction of Sequence	12.01.2017

Composition

deferasiroxum 180 mg, cellulosum microcristallinum, crospovidonum, povidonum K 30, magnesii stearas, silica colloidalis anhydrica, poloxamerum 188, Überzug: hypromellosum, macrogolum 4000, talcum, E 132, E 171 pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Deferasirox	180 mg

BAG: Active Agent	Dose
Deferasirox	180 mg

Inactive agents	Dose	additional_information
Cellulosum Microcristallinum
Crospovidonum
E 132		color.
E 171		color.
Hypromellosum		Überzug
Macrogol	4000
Magnesii Stearas
Poloxamer	188
Povidonum K	30
Pro Compresso Obducto
Silica Colloidalis Anhydrica
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003	30	313.58	352.65	B	SL	No
004	90	799.62	873.75	B	SL	No

2025	©ywesee GmbH